Persistent Depressive Disorder (Dysthymia)

DBCOND0128618Mental Disorders

Persistent Depressive Disorder (Dysthymia) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Dysthymic Disorder · Dysthymia · Persistent Depressive Disorder · Persistent Depressive Disorder, Dysthymia · Persistent Depressive Disorder (PDD)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0028689ICD-10F32.ASNOMED CT1153575004MedDRA10012401UMLSC0011581

What you can answer from here — as of October 25, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
37Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Persistent Depressive Disorder (Dysthymia) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In